ArticleVaccines2024

Insights into the Pathogenesis and Development of Recombinant Japanese Encephalitis Virus Genotype 3 as a Vaccine.

Jae-Yeon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.